Benjamin Saks
Orthopaedic Surgery · Exeter, NHNPI 1003235516
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (55.0%), education and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 55.5% of the total. Reporting peaked in 2021 at $14,223 and has fallen 94.5% since, to $782 in 2025.
Across 54 payments — averaging $673.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Smith+Nephew$8K
- Medwest Associates$4K
- Kairos Surgical Inc$3K
- Stryker$1K
- Pacira Pharmaceuticals Incorporated$182
- plus $637 from 8 others
What the payments were for
- Grants$20,00055%
- Travel & lodging$2511%
- Food & beverage$2,4247%
- Education$13,67038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 3 | $20,172 |
| Smith+Nephew | 3 | $7,612 |
| Medwest Associates | 6 | $3,846 |
| Kairos Surgical Inc | 6 | $2,580 |
| Stryker | 23 | $1,315 |
| Pacira Pharmaceuticals Incorporated | 2 | $182 |
| Medacta USA, Inc. | 1 | $123 |
| Anika Therapeutics, Inc. | 1 | $113 |
| Skeletal Dynamics Inc | 1 | $107 |
| Pacira Therapeutics, Inc. | 1 | $98 |
| Acumed LLC | 1 | $83 |
| Johnson & Johnson(2 entities) | 3 | $63 |
| AbbVie | 2 | $38 |
| Si-bone, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,345 in reported general payments places this provider in the 85th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 16 | $627 |
| Meloxicam | 19 | $118 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Exeter
- Robert BearExeter$53K
- Akhilesh SastryPortsmouth$966K
- Mayo NoerdlingerPortsmouth$529K
- John-Erik BellLebanon$528K
- Michael MorwoodPortsmouth$506K
- Ira ParsonsSomersworth$245K
- Alexander OremLebanon$215K
- David RichardsNashua$122K
- Philip WolinskyLebanon$110K
- Ida GitajnLebanon$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.